Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: Proceedings of the International Symposium on Animal Genomics for Animal Health (AGAH 2010)

Open Access Proceedings

Genetic and cellular aspects of the establishment of histocompatible stem cells: information gained from an animal model

Jeong Mook Lim12* and Seung Pyo Gong3

Author Affiliations

1 WCU Biomodulation Program, Seoul National University, Seoul 151-742, Korea

2 Department of Agricultural Biotechnology, Seoul National University 151-921, Korea

3 Department of Marine Biomaterials and Aquaculture, College of Fisheries Science, Pukyong University, Busan 608-737, Korea

For all author emails, please log on.

BMC Proceedings 2011, 5(Suppl 4):S31  doi:10.1186/1753-6561-5-S4-S31

Published: 3 June 2011


The establishment of patient-specific histocompatible stem cells may be an alternative for overcoming current limitations in stem cell engineering. We are developing an animal model to assist the establishment of histocompatible, autologous stem cells. In this process, we obtained valuable information on establishing and characterizing stem cells. As an initial step, we succeeded in establishing histocompatible stem cells using preantral follicle cultures and subsequent parthenogenetic activation. The gene expression profile of the established stem cells was similar to that of embryonic stem cells (ESCs) derived from normal fertilization. On the other hand, we propose a way to derive histocompatible, ESC-like cells by co-culturing ovarian stromal cells with feeder fibroblasts, which may allow the derivation of stem cells from somatic tissue. However, more progress regarding the establishment and elucidation on origination of established cell lines is necessary to use this genetic manipulation-free procedure. Nevertheless, relevant information on the process will help to stimulate preclinical research on cell transformation into differentiated, undifferentiated, and even cancerous cells, as well as clinical studies on the application of induced pluripotent cells.